The Biden administration is once again planning to extend the COVID-19 “public health emergency,” allowing pharmaceutical companies who manufacture vaccines and COVID “treatments” to bypass regulatory standards and giving them the continued benefits of liability protection for the harms caused by their experimental products.
With bivalent COVID-19 boosters — which have not been properly tested for safety or efficacy — projected to be available in October, extending the declaration is necessary to authorize boosters for emergency use.
How else could a new drug without adequate clinical trials find its way to the market and have liability protection?
Under the proposed extension, the Department of Health and Human Services would continue the declaration beyond the November mid-term elections and potentially into early 2023, which would push the U.S. into its fourth year under a “COVID-19 public health emergency.”
“COVID is not over. The pandemic is not over,” a senior Biden official told Politico. “It doesn’t make sense to lift this [declaration] given what we’re seeing on the ground in terms of cases.”
“It will end whenever the emergency ends,” another senior administration official said, summing up the internal attitude toward the declaration.
The emergency designation has allowed the administration to “greenlight vaccines” more quickly and has allowed pharmaceutical companies to bypass regulatory standards that are designed to ensure a product is safe and effective.
As long as a declaration is in place, COVID-19 vaccines are covered under the Public Readiness and Emergency Preparedness Act and a vaccine injured person’s only recourse for obtaining compensation for their paralysis, blood clots, neurological damage and heart problems caused by a COVID vaccine is through the government’s Countermeasures Injury Compensation Program — which has only approved 2 of thousands of vaccine injury claims and has not paid anything out for these injuries to date.
The emergency declaration has allowed drugs like Remdesivir, Paxlovid, and molnupiravir to be administered to people with COVID despite the fact that these drugs do not work and are only supported by the bare minimum of bad “science” submitted in favor of their authorization.
The federal government has continuously renewed the declaration since January 2020 and the current administration has refused to set out specific criteria for phasing out its emergency authorities. Does the federal government ever want to “give up” power?
As far as the Biden administration is concerned, the “COVID emergency” is indefinite. Too many people are getting rich and thousands of people would be filing lawsuits for their injuries if liability protection disappeared. It’s the perfect arrangement for the government and pharmaceutical companies, who we know at this point are colluding with each other to achieve their mutual goals.
If the emergency declaration were ended, pharmaceutical companies and the Biden administration would not be able to use the “fear” of a “pandemic” to sell their vaccines and push their mandates, nor would they be able to get Congress to allocate more U.S. tax dollars to frivolous causes under the guise of a COVID-19 emergency.